重症监护医学学会2024年危重儿童和成人血糖控制指南
该指南由重症监护医学学会(SCCM)组织22人多专业工作组,采用GRADE方法系统评价危重儿童(校正胎龄≥42周至18岁)和成人血糖管理证据,更新2012版指南。针对未选择的成人共发布7条声明(2条良好实践声明、4条条件性推荐、1条研究声明),针对儿科患者发布7条声明(2条良好实践声明、1条强推荐、1条条件性推荐、2条「在我们的实践中」声明、1条研究声明)。核心推荐为高血糖急性期首选胰岛素输注,由明确临床决策支持工具引导滴定,血糖不稳定期间监测间隔≤1小时以尽量减少低血糖,不推荐强化血糖目标。推荐需结合患者现有临床状态考虑。
要点
- 成人未选择人群:2条良好实践声明、4条条件性推荐、1条研究声明,核心为高血糖急性期首选胰岛素输注。
- 儿科患者:1条强推荐、1条条件性推荐、2条良好实践声明、2条「在我们的实践中」声明、1条研究声明。
- 胰岛素输注滴定应由明确临床决策支持工具引导。
- 血糖不稳定期间监测间隔≤1小时,以尽量减少低血糖。
- 不推荐以强化血糖水平为目标。
适用人群与场景
- 危重儿童:校正胎龄≥42周至18岁。
- 危重成人。
- 适用于成人及儿科执业医师重新评估当前实践。
处置流程与药物剂量
- 高血糖急性期首选胰岛素输注。
- 胰岛素输注滴定由明确临床决策支持工具引导。
- 血糖不稳定期间监测间隔≤1小时,以尽量减少低血糖。
- 不推荐以强化血糖水平为目标。
- 推荐需在患者现有临床状态框架内考虑。
研究设计与关键结果
- 指南为2012年重症监护医学学会和美国重症监护医学院(ACCM)指南的更新,基于新系统评价。
- 工作组共22人,包括临床医生、患者/家属倡导者及方法学家,采用GRADE方法。
- 成人未选择人群共7条声明:2条良好实践声明、4条条件性推荐、1条研究声明。
- 儿科患者共7条声明:2条良好实践声明、1条强推荐、1条条件性推荐、2条「在我们的实践中」声明、1条研究声明。
- 系统评价覆盖的问题包括启动胰岛素治疗的触发因素、给药途径、监测频率、明确决策支持工具在方案维持中的作用及血糖检测方法。
证据类型、等级与局限
- 证据类型:指南(基于系统评价,采用GRADE方法)。
- 推荐强度按GRADE分为强推荐、弱推荐或良好实践声明。
- 证据不足以支持推荐时,纳入「在我们的实践中」声明描述专家组实践模式。
- 局限:原文未报告局限性。
对床旁实践的改变
- 成人及儿科危重患者高血糖急性期首选胰岛素输注,以明确临床决策支持工具引导滴定。
- 血糖不稳定期间监测间隔≤1小时,以尽量减少低血糖。
- 不推荐以强化血糖水平为目标。
- 原文未据此给出其他推荐。
指南或共识出处
- Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024(重症监护医学学会2024年危重儿童和成人血糖控制指南),发表于Critical Care Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Maintaining glycemic control of critically ill patients may impact outcomes such as survival, infection, and neuromuscular recovery, but there is equipoise on the target blood levels, monitoring frequency, and methods.
OBJECTIVES: The purpose was to update the 2012 Society of Critical Care Medicine and American College of Critical Care Medicine (ACCM) guidelines with a new systematic review of the literature and provide actionable guidance for clinicians.
PANEL DESIGN: The total multiprofessional task force of 22, consisting of clinicians and patient/family advocates, and a methodologist applied the processes described in the ACCM guidelines standard operating procedure manual to develop evidence-based recommendations in alignment with the Grading of Recommendations Assessment, Development, and Evaluation Approach (GRADE) methodology. Conflict of interest policies were strictly followed in all phases of the guidelines, including panel selection and voting.
METHODS: We conducted a systematic review for each Population, Intervention, Comparator, and Outcomes question related to glycemic management in critically ill children (≥ 42 wk old adjusted gestational age to 18 yr old) and adults, including triggers for initiation of insulin therapy, route of administration, monitoring frequency, role of an explicit decision support tool for protocol maintenance, and methodology for glucose testing. We identified the best available evidence, statistically summarized the evidence, and then assessed the quality of evidence using the GRADE approach. We used the evidence-to-decision framework to formulate recommendations as strong or weak or as a good practice statement. In addition, "In our practice" statements were included when the available evidence was insufficient to support a recommendation, but the panel felt that describing their practice patterns may be appropriate. Additional topics were identified for future research.
RESULTS: This guideline is an update of the guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. It is intended for adult and pediatric practitioners to reassess current practices and direct research into areas with inadequate literature. The panel issued seven statements related to glycemic control in unselected adults (two good practice statements, four conditional recommendations, one research statement) and seven statements for pediatric patients (two good practice statements, one strong recommendation, one conditional recommendation, two "In our practice" statements, and one research statement), with additional detail on specific subset populations where available.
CONCLUSIONS: The guidelines panel achieved consensus for adults and children regarding a preference for an insulin infusion for the acute management of hyperglycemia with titration guided by an explicit clinical decision support tool and frequent (≤ 1 hr) monitoring intervals during glycemic instability to minimize hypoglycemia and against targeting intensive glucose levels. These recommendations are intended for consideration within the framework of the patient's existing clinical status. Further research is required to evaluate the role of individualized glycemic targets, continuous glucose monitoring systems, explicit decision support tools, and standardized glycemic control metrics.
参考来源
- Honarmand K, Sirimaturos M, Hirshberg EL, et al. Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024. Crit Care Med. 2024. PMID: 38240484. doi:10.1097/CCM.0000000000006174
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。